Lv61
2800 积分 2020-06-07 加入
Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma
13天前
已关闭
Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma
13天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
1个月前
已完结
Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity
2个月前
已完结
Impact of dextran sulfate in culture media on titration of vesicular stomatitis virus
2个月前
已完结
CD55-displaying oncolytic vaccinia virus treated metastatic cancers by evading the effect of host innate and adaptive humoral responses
3个月前
已完结
Engineering viral vectors for in vivo CAR-T generation: Advances, challenges, and opportunities
3个月前
已完结
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
3个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
4个月前
已完结
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial
6个月前
已完结
皖公网安备34019202002308
